MKI67 and neoplasm: Moreover, HBV-miR-2 antagomir could remarkably decrease the percentage of the Ki67 positive Huh7 cells (Fig. S8B and S8C), suggesting that HBV-miR-2 antagomir could restrain tumor growth by inhibiting cell proliferation.